• Study on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy
  • Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

    Not recruiting

    1 1 1 1
    Bulgaria
  • Study on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Poland
  • Study of Isatuximab for Patients with Type I Cryoglobulinemia

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Poland
  • Study of Azenosertib and Niraparib for Patients with Platinum-Resistant Ovarian Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Autologous Chondrocytes and Remestemcel for Knee Cartilage Lesions in Patients with Symptomatic Articular Cartilage Damage

    Not recruiting

    3 1 1
    Investigated diseases:
    The Netherlands
  • Study on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Germany Latvia Poland +3

powered by